Cargando…
Gut Microbiota as a Potential Predictive Biomarker in Relapsing-Remitting Multiple Sclerosis
Background: The influence of the microbiome on neurological diseases has been studied for years. Recent findings have shown a different composition of gut microbiota detected in patients with multiple sclerosis (MS). The role of this dysbiosis is still unknown. Objective: We analyzed the gut microbi...
Autores principales: | Navarro-López, Vicente, Méndez-Miralles, María Ángeles, Vela-Yebra, Rosa, Fríes-Ramos, Ana, Sánchez-Pellicer, Pedro, Ruzafa-Costas, Beatriz, Núñez-Delegido, Eva, Gómez-Gómez, Humberto, Chumillas-Lidón, Sara, Picó-Monllor, Jose A., Navarro-Moratalla, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140870/ https://www.ncbi.nlm.nih.gov/pubmed/35627315 http://dx.doi.org/10.3390/genes13050930 |
Ejemplares similares
-
Selection of Probiotics in the Prevention of Respiratory Tract Infections and Their Impact on Occupational Health: Scoping Review
por: Picó-Monllor, José Antonio, et al.
Publicado: (2021) -
Probiotics in the Therapeutic Arsenal of Dermatologists
por: Navarro-López, Vicente, et al.
Publicado: (2021) -
Acne, Microbiome, and Probiotics: The Gut–Skin Axis
por: Sánchez-Pellicer, Pedro, et al.
Publicado: (2022) -
Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by Clostridiodes difficile
por: Sánchez-Pellicer, Pedro, et al.
Publicado: (2021) -
Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial
por: Navarro-López, Vicente, et al.
Publicado: (2022)